首页 | 本学科首页   官方微博 | 高级检索  
     

膀胱移行细胞癌组织bcl—2及P53基因表达的临床意义
引用本文:陈廷 曹卉. 膀胱移行细胞癌组织bcl—2及P53基因表达的临床意义[J]. 济宁医学院学报, 1999, 22(4): 4-6
作者姓名:陈廷 曹卉
作者单位:济宁医学院微生物学教研室(陈廷,曹卉,衣美英,朱伟,李秀真,刘昌平,山长武),临沂市肿瘤医院(王春英)
基金项目:山东省自然科学基金!(Y95C0931)
摘    要:
目的 研究抑凋亡基因bcl- 2 和P53 表达与膀胱移行细胞癌间的关系。方法 采用免疫组化SP法观察75 例膀胱癌组织中bcl- 2 基因产物和突变型P53 蛋白表达。结果 bcl- 2 和P53 蛋白阳性表达率分别为40 % 和44 % ,bcl-2 和P53 阳性率与肿瘤侵袭性和淋巴结及远处转移有密切的关系( P< 0 .05) ,但与组织学分级无明显关系( P> 0 .05) 。结论 结果提示,bcl- 2 与P53 表达在膀胱癌发生中可能起协同作用,bcl- 2 可作为评估肿瘤恶性程度、侵袭性和转移的重要参考指标之一。

关 键 词:膀胱肿瘤  基因  免疫组化

EXPRESSION OF APOPTOSIS-SUPRESSING ONCOPROTEIN BCL-2 AND MUTANT P53 IN BLADDER CARCINOMA
Chen Ting,Cao Hui,Yi Meiying,et al.. EXPRESSION OF APOPTOSIS-SUPRESSING ONCOPROTEIN BCL-2 AND MUTANT P53 IN BLADDER CARCINOMA[J]. Jounal of Jinning Medical College, 1999, 22(4): 4-6
Authors:Chen Ting  Cao Hui  Yi Meiying  et al.
Abstract:
Objective We study the corelation of the apoptosis-supressing oncoprotein bcl-2 and P53 expression with bladder carcinoma. Methods The apoptosis-supressing oncoprotein bcl-2 and mutant P53 protein were assayed by immunohistochemical technique in 75 cases of bladder carcinoma.Results Positive rates of bcl-2 oncoprotein and P53 protein were 40% and 44%,respectively. The results showed that bcl-2 and P53 protein were related to the clinic stage and metastasis(P<0.05), but was not related to the tumor grade (P>0.05). Conclusion The data showed that apoptosis-supressing oncoprotein bcl-2 and mutant P53 protein play an important role in the genesis and malignant progression of bladder carcinoma, bcl-2 might be applicable as a tumor marker for the maligant potential and metastasis
Keywords:Bladder carcinoma  Gene  Immunohistochemisty  
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号